Customer Service

LABConnect™ - Online Results & More

Tutorial | Create Account | Login

USP Method <797>

Category Consumer Products Testing
Test USP Method <797>: Pharmecuetical Compounding - Sterile Preparations
Description

Download the PDF Version

The new USP 797 guidelines are designed to prevent the improper handling and contamination of sterile compounds for certain drugs or biologic preparations. These items include:
1) baths for live tissues and organs
2) opthalmics
3) parenterals
4) tissue implants
5) aqueous nasal and bronchial inhalations
6) irrigating solutions.

 

The guidelines impact not only the people who prepare the compounded sterile pharmaceuticals (CSPs) but also the areas where theses drugs are prepared and stored including commercial and hospital pharmacies, clinics, doctor’s offices and other facilities. USP 797 recommends certain clean area designs, storage specifications, Quality Assurance plans which include environmental monitoring, and employee training programs to accomplish the safe handling of these preparations.  These guidelines specifically address:
1) microbial contamination
2) endotoxins
3) physical or chemical contamination
4) preparation of incorrect concentrations and
5) incorrect ingredients. 
A mistake in any of these 5 areas can cause serious injury or even death.

 

While a good portion of the USP 797 guidelines deal with improving air quality in these facilities, an equally important goal is to prevent physical contact with and contamination of these preparations during manufacture.  Products are manufactured according to risk levels: low, medium or high.  Products that are to be injected carry the greatest risk of serious health effects; therefore these products must be manufactured in an area having the lowest risk level for contamination.  The lowest risk level required under USP 797 for a critical area is an ISO Class 5 area designation.

 

The design of Class 5 clean areas for preparation and Class 7 buffer areas, surrounding Class 5 areas, is a requirement.  Semi-annual monitoring for viable bacteria in air, fingertip, surface contact plates, and particulates is required for both Class 5 and Class 7 designated areas. These monitoring results trended over time will provide information on any deterioration in air quality and aseptic technique.  Generally, this monitoring should be conducted semi-annually.

 

The action levels for microbial and particulate monitoring results are summarized below:

 

Semi-Annual Microbial and Particulate Monitoring

ISO Clean Room Classification

US Clean Room Classification

(0.5 u/ft3)

Particulate

Sampling

> 0.5 u/m3

Air Sampling

400-1000 L*

 

CFU/m3

 

Fingertip Sampling

Total

CFU/Plate

Swab/Surface Contact Plate

Sampling 

CFU/Plate

Endotoxin (frequency depends on CSP batch numbers/  storage conditions)

Class 5

100

3520

>1

>3

>3

See USP monographs

Class 7

1000

352,000

>10

NA

>5

See USP monographs

Class 8

10,000

3,520,000

>100

NA

>100

See USP monographs

* Based on sample volume of 100 lpm

 

One important item should be noted.  Regardless of the number of CFUs recovered, corrective actions are required if any of the following organisms are identified: 1) Gram negative rods, 2) Coagulase positive Staphylococcus,and 3) Molds and Yeasts. 

 

For more information concerning these guidelines, please call Diane Miskowski at 800-220-3675 x1218.


Ann Arbor, MI - NVLAP Lab Code 101048-4Atlanta, GA - NVLAP Lab Code 101048-1Baton Rouge, LA - NVLAP Lab Code 200375-0Beltsville, MD - NVLAP Lab Code 200293-0Boston, MA - NVLAP Lab Code 101147-0Buffalo, NY - NVLAP Lab Code 200056-0Calgary, Alberta - NVLAP Lab Code 500100-0Carle Place, NY - NVLAP Lab Code 101048-10Charlotte, NC - NVLAP Lab Code 200841-0Chicago, IL - NVLAP Lab Code 200399-0Corporate - Cinnaminson, NJ - NVLAP Lab Code 101048-0Dallas, TX - NVLAP Lab Code 600111-0Denver, CO - NVLAP Lab Code 200828-0EMSL Canada - Montreal -- Quebec - NVLAP Lab Code 201052-0EMSL Canada -- Toronto - NVLAP Lab Code 200877-0EMSL Canada Inc. -- Ottawa - NVLAP Lab Code 201040-0Fort Lauderdale - NVLAP Lab Code 500085-0Houston, TX - NVLAP Lab Code 102106-0Huntington Beach, CA - NVLAP Lab Code 101384-0Indianapolis, IN - NVLAP Lab Code 200188-0Inland Empire, CA - NVLAP Lab Code 600239-0Kernersville, NC - NVLAP Lab Code 102104-0Las Vegas, NV - NVLAP Lab Code 600140-0Miami, FL - NVLAP Lab Code 200204-0Minneapolis, MN - NVLAP Lab Code 200019-0New York, NY - NVLAP Lab Code 101048-9Orlando, FL - NVLAP Lab Code 101151-0Pasadena, CA - NVLAP Lab Code 200232-0Phoenix, AZ - NVLAP Lab Code 200811-0Piscataway, NJ - NVLAP Lab Code 101048-2Plymouth Meeting, PA - NVLAP Lab Code 200699-0Raleigh, NC - NVLAP Lab Code 200671-0Rochester, NY - NVLAP Lab Code 600183-0S. Portland, ME - NVLAP Lab Code 500094-0Salem, NH - NVLAP Lab Code 201051-0San Diego, CA - NVLAP Lab Code 200855-0San Leandro, CA - NVLAP Lab Code 101048-3Seattle, WA - NVLAP Lab Code 200613-0St. Louis, MO - NVLAP Lab Code 200742-0Tampa, FL - NVLAP Lab Code 600215-0Vancouver, BC - NVLAP Lab Code 201068-0Wallingford, CT - NVLAP Lab Code 200700-0West Palm Beach, FL - NVLAP Lab Code 600206-0Weymouth, MA - NVLAP Lab Code 600217-0
Sorry, this function is disabled.